Skip to main content Accessibility help

Strategies for Study of the Role of Cycling on Antimicrobial Use and Resistance

  • John E. McGowan (a1)


Resistant bacteria usually are seen first in the intensive care unit and other acute-care areas. Thus, strategies to control these organisms often are first tested in these healthcare settings. Frequent among these strategies are attempts to improve antimicrobial use. One proposed method to decrease resistance in special settings like the intensive care unit is the cycling or rotation of antimicrobials. This intervention must be evaluated in the context of other concomitant attempts to improve antimicrobial usage and must take into account other factors influencing resistance.

Until such studies are done, the value of cycling and other efforts to limit prescribers' choices of drugs in endemic settings will be unclear. Studies to evaluate cycling will have to be of large scale to produce useful data. It is unlikely that many hospitals or healthcare systems will have sufficient resources on their own to develop studies of sufficient power to be applied widely. Thus, cooperative studies to provide data on this important issue should be an international priority.


Corresponding author

Epidemiology Department (Room 442 GCR), Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322


Hide All
1.Tenover, FC, McGowan, JE Jr. Epidemiology and molecular biology of antimicrobial resistance in bacteria. In: Nelson, AM, Horsburgh, CR Jr, eds. Pathology of Emerging Infections—2. Washington, DC: American Society for Microbiology Press; 1998:343360.
2.Sanders, WE Jr, Sanders, CC. Circumventing antibiotic resistance in specialized hospital units. Clin Microbiol Infect 1997;3:272273.
3.McGowan, JE Jr, Tenover, FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297311.
4.Goosens, H, Sprenger, MJW. Community acquired infections and bacterial resistance. BMJ 1998;317:654657.
5.Gniadkowski, M, Palucha, A, Grzesiowski, P, Hryniewicz, W. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene. Antimkrob Agents Chemother 1998;42:30793085.
6.O'Brien, FG, Pearman, JW, Gracey, M, Riley, TV, Grubb, WB. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 1999;37:28582862.
7.Trick, WE, Kuehnert, MJ, Quirk, SB, Arduino, MJ, Aguero, SM, Carson, LA, et al. Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999;180:391396.
8.McGowan, JE Jr. Drug resistance and nosocomial infections: epidemiology and prevention strategies. In: Finch, RG, Williams, RJ, eds. Balliere's Clinical Infectious Diseases. London, UK: Balliere Tindall; 1999;5:177192.
9.Amyes, SGB. Genes and spectrum: the theoretical limits. Clin Infert Dis 1998;27(suppl 1):S21S28.
10.Hawkey, PM. The origins and molecular basis of antibiotic resistance. BMJ 1998;317:657660.
11.Kim, W-J, Weinstein, RA, Hayden, MKThe changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999;179:163171.
12.Tenover, FC, McGowan, JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996;311:916.
13.Baquero, F, Negri, M-C, Morosini, M-I, Blazquez, J. Antibiotic-selective environments. Clin Infect Dis 1998;27(suppl 1):S5S11.
14.McGowan, JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478483.
15.Johnson, AP. Antibiotic resistance among clinically important gram-positive bacteria in the UK J Hosp Infect 1998;40:1726.
16.Monnet, DL, Archibald, LK, Phillips, L, Tenover, FC, McGowan, JE Jr, Gaynes, RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infection Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998;19:388394.
17.Fridkin, SK, Steward, CD, Edwards, JR, Pryor, ERMcGowan, JE Jr, Archibald, LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245252.
18.Archibald, L, Phillips, L, Monnet, D, McGowan, JE Jr, Tenover, F, Gaynes, RAntimicrobial resistance in isolates from inpatients and outpatients in the United States: the increasing importance of the intensive care unit. Clin Inject Dis 1997;24:211215.
19.Gaynes, RMonnet, D. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals. In: Antibiotic Resistance: Origins, Evolution, Selection, and Spread. Ciba Foundation Symposium 207. Chichester, England: John Wiley and Sons; 1997:4760.
20.Fridkin, SK, Edwards, JRPichette, SC, Pryor, ER, McGowan, JE Jr, Tenover, FC, et al. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999;28:11191125.
21.Wenzel, RP, Wong, MT. Editorial response: managing antibiotic use— impact of infection control. Clin Infert Dis 1999;28:11261127.
22.Polk, ROptimal use of modern antibiotics: emerging trends. Clin Infect Dis 1999;29:264274.
23.McGowan, JE Jr. Ways and means to influence antimicrobial prescribing in healthcare and its impact on resistance. In: Andremont, A, Brun-Buisson, C, McGowan, JE Jr, eds. Maurice Rapin Colloquia: Antibiotic Therapy and Control of Antimicrobial Resistance in Hospitals. Paris, France: Elsevier; 1999:97105.
24.McGowan, JE Jr, Gerding, DN. Does antibiotic restriction prevent resistance? New Horizons 1996;4:370376.
25.Munoz, RCoffey, TJ, Daniels, M, Dowson, CG, Laible, G, Casal, J, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302306.
26.Belongia, EA, Schwartz, B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ 1998;317:668671.
27.Burke, JP. Antibiotic resistance—squeezing the balloon? JAMA 1998;280:12701271.
28.Stosor, V, Peterson, LRPostelnick, M, Noskin, GA. Enterococcus faecium bacteremia—does vancomycin resistance make a difference? Arch Intern Med 1998;158:522527.
29.Turnidge, J. What can be done about resistance to antibiotics? BMJ 1998;317:645647.
30.Phillips, I. Lessons from the past: a personal view. Clin Infect Dis 1998;27(suppl 1):S2S4.
31.Marwick, C. Animal feed antibiotic use raises drug resistance iear. JAMA 1999;282:120122.
32.Helmuth, RProtz, D. How to modify conditions limiting resistance in bacteria in animal and other reservoirs. Clin Infect Dis 1997;24(suppl 1):S136S138.
33.Duncan, RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260266.
34.Lipsky, BA, Baker, CA, McDonald, LL, Suzuki, NT. Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control 1999;27:8490.
35.Metlay, JP, Stafford, RS, Singer, DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 1998;158:18131818.
36.Levy, SB. Multidrug resistance—a sign of the times. N Engl J Med 1998;338:13761378.
37.Kollef, MH, Sherman, G, Ward, S, Fraser, VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462474.
38.McGowan, JE Jr. Antibiotic-resistant bacteria and healthcare systems— four steps for effective response. Infect Control Hosp Epidemiol 1995;18:6770.
39.Schentag, JJ. Antibiotic dosing—does one size fit all? JAMA 1998;279:159160.
40.Classen, DC. Clinical decision support systems to improve clinical practice and quality of care. JAMA 1998;280:13601361.
41.Kolmos, HJ, Little, P. Should general practitioners perform diagnostic tests on patients before prescribing antibiotics? BMJ 1999;318:799802.
42.Martin, C, Pourriat, JL. Quality of perioperative antibiotic administration by French anaesthetists. J Hosp Infect 1998;40:4753.
43.Pichichero, ME. Changing the treatment paradigm for acute otitis media in children. JAMA 1998;279:17481750.
44.Culpepper, L, Froom, J. Routine antimicrobial treatment of acute otitis media: is it necessary? JAMA 1997;278:16431645.
45.Hamilton-Miller, JMT. Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clin Microbiol Infection 1996;2:1219.
46.Parker, SE, Nathwani, D, O'Reilly, D, Parkinson, S, Davey, PG. Evaluation of the impact of non-inpatient IV antibiotic treatment for acute infections on the hospital, primary care services and the patient. J Antimkrob Chemother 1998;42:373380.
47.Dunagan, WC, Medoff, G. Formulary control of antimicrobial usage. What price freedom? Diagn Mkrobiol Infect Dis 1993;16:265274.
48.Landman, D, Chockalingam, M, Quale, JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:10621068.
49.Schentag, JJ, Hyatt, JM, Carr, JR, Paladino, JA, Birmingham, MC, Zimmer, GS, et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 1998;26:12041214.
50.Evans, ME, Mulheim, ET, Rapp, RP. Vancomycin use in a university medical center: effect of a vancomycin continuation form. Infect Control Hosp Epidemiol 1999;20:417420.
51.Pena, C, Pujol, M, Ardanuy, C, Ricart, A, Pallares, R, Linares, J, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimkrob Agents Chemother 1998;42:5358.
52.Quale, J, Landman, D, Saurina, G, Atwood, E, Ditore, V, Patel, K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:10201050.
53.Rahal, JJ, Urban, C, Horn, D, Freeman, K, Segal-Maurer, S, Maurer, J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in Klebsiella. JAMA 1998;280:12331237.
54.White, AC Jr, Atmar, RL, Wilson, J, Cate, TR, Stager, CE, Greenberg, SB. Effects of requiring prior authorization for selected antimicrobials; expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230239.
55.Mitchell, P. Antibiotic swings and roundabouts. Lancet 1998;352:1288.
56.Postelnick, MJ, Peterson, LR, Noskin, GAEffect of changes in antimicrobial agent use on bacterial pathogens recovered from hospitalized patients: a 6-year assessment. J Clinical Outcomes Management 1998;5:2132.
57.Schwartz, B, Bell, DM, Hughes, JM. Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA 1997;278:944945.
58.van der Zwet, WC, Parlevliet, GASavelkoul, PH, Stoof, J, Kaiser, AM, Koeleman, JG, et al. Nosocomial outbreak of gentamicin-resistant Klebsiella pneumoniae in a neonatal intensive care unit controlled by a change in antibiotic policy. J Hosp Infect 1999;42:295302.
59.Moellering, RC Jr. Antibiotic resistance: lessons for the future. Clin Infect Dis 1998;27(suppl 1):S135S140.
60.Heizmann, WR. Circumventing antibiotic resistance in specialized hospital units. Clin Microbiol Infect 1997;3:133134.
61.Rice, LB. Editorial response: a silver bullet for colonization and infection with methicillin-resistant Staphylococcus aureus still eludes us. Clin Infect Dis 1999;28:10671070.
62.Friedrich, LV, White, RL, Bosso, JAImpact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis 1999;28:10171024.
63.Streulens, MJ, Byl, B, Vincent, J-LAntibiotic policy: a tool for controlling resistance of hospital pathogens. Clin Microbiol Infect 1999;5(suppl):S19S24.
64.Gerding, DN, Larson, TAHughes, RAWeiler, M, Shanholtzer, C, Peterson, LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimkrob Agents Chemother 1991;35:12841290.
65.Bonten, MJM, Slaughter, S, Ambergen, AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci. An important infection control variable. Arch Intern Med 1998;158:11271132.
66.Boyce, JM. It is time for action: improving hand hygiene in hospitals. Ann Intern Med 1999;130:153155.


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed